Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy

M Spreafico, M Cafora, C Bragato, D Capitanio… - Pharmacological …, 2021 - Elsevier
Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle degeneration
and currently there are few therapeutic options. The identification of new drug targets and …
被引用次数：22 相关文章

Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy

M Spreafico, M Cafora, C Bragato, D Capitanio… - PHARMACOLOGICAL …, 2021 - air.unimi.it
Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle degeneration
and currently there are few therapeutic options. The identification of new drug targets and …

Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy.

M Spreafico, M Cafora, C Bragato… - Pharmacological …, 2021 - europepmc.org
Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle degeneration
and currently there are few therapeutic options. The identification of new drug targets and …

Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy

M Spreafico, M Cafora, C Bragato… - PHARMACOLOGICAL …, 2021 - boa.unimib.it
Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle degeneration
and currently there are few therapeutic options. The identification of new drug targets and …

Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy

M Spreafico, M Cafora, C Bragato… - Pharmacological …, 2021 - pubmed.ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle degeneration
and currently there are few therapeutic options. The identification of new drug targets and …